Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Brain neoplasm
ADR ID BADD_A05768
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.30      Nervous system neoplasms malignant and unspecified NEC
16.30.01      Nervous system neoplasms unspecified malignancy NEC
16.30.01.003      Brain neoplasm
17      Nervous system disorders
17.20      Nervous system neoplasms malignant and unspecified NEC
17.20.01      Nervous system neoplasms unspecified malignancy NEC
17.20.01.003      Brain neoplasm
Description Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. [MeSH]
MedDRA Code 10061019
MeSH ID D001932
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Brain neoplasm NOS | Brain tumor | Brain tumor NOS | Brain tumor NOS [Ref.20909] | Brain tumour NOS | Neoplasm of unspecified nature of brain | Brain neoplasm | Brain tumour | Intracranial tumour | Intracranial tumor | Brain Neoplasms | Neoplasms, Brain | Brain Neoplasm | Neoplasm, Brain | Brain Tumors | Brain Tumor | Tumor, Brain | Tumors, Brain | Brain Cancer | Brain Cancers | Cancer, Brain | Cancers, Brain | Malignant Neoplasms, Brain | Brain Malignant Neoplasm | Brain Malignant Neoplasms | Malignant Neoplasm, Brain | Cancer of Brain | Cancer of the Brain | Neoplasms, Brain, Malignant | Brain Neoplasms, Malignant | Brain Neoplasm, Malignant | Malignant Brain Neoplasm | Malignant Brain Neoplasms | Neoplasms, Intracranial | Intracranial Neoplasm | Neoplasm, Intracranial | Intracranial Neoplasms | Brain Tumor, Recurrent | Brain Tumors, Recurrent | Recurrent Brain Tumor | Recurrent Brain Tumors | Malignant Primary Brain Tumors | Primary Malignant Brain Tumors | Malignant Primary Brain Neoplasms | Primary Malignant Brain Neoplasms | Brain Neoplasms, Malignant, Primary | Brain Neoplasms, Primary Malignant | Benign Neoplasms, Brain | Benign Neoplasm, Brain | Brain Benign Neoplasm | Brain Benign Neoplasms | Neoplasms, Brain, Benign | Brain Neoplasms, Benign | Benign Brain Neoplasm | Benign Brain Neoplasms | Brain Neoplasm, Benign | Brain Tumor, Primary | Brain Tumors, Primary | Primary Brain Tumor | Primary Brain Tumors | Neoplasms, Brain, Primary | Brain Neoplasm, Primary | Brain Neoplasms, Primary | Primary Brain Neoplasm | Primary Brain Neoplasms
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00047Afatinib0.000112%
BADD_D00066Alendronic acid0.000044%
BADD_D00110Aminolevulinic acid--
BADD_D00121Amlodipine0.000006%
BADD_D00151Apixaban0.000325%
BADD_D00165Aripiprazole0.000119%
BADD_D00193Axitinib0.000112%
BADD_D00194Azacitidine0.000168%
BADD_D00285Bosentan0.000181%
BADD_D00329Cabergoline0.004804%
BADD_D00349Capecitabine0.000414%
BADD_D00356Carbamazepine0.000372%
BADD_D00364Carboplatin0.000112%
BADD_D00371Carmustine--
BADD_D00410Celecoxib0.000050%
BADD_D00511Clozapine0.026903%
BADD_D00535Crizotinib0.000302%
BADD_D00563Dabigatran0.001346%
BADD_D00566Dabrafenib0.000437%
BADD_D00599Degarelix--
BADD_D00653Diclofenac0.000026%
BADD_D00680Dimethyl fumarate0.002961%
BADD_D00759Eltrombopag0.000229%
BADD_D00775Enzalutamide0.000901%
BADD_D00800Erlotinib0.000224%
BADD_D00821Estradiol--
BADD_D00858Everolimus0.000535%
BADD_D00861Exemestane--
BADD_D00864Ezetimibe0.000063%
BADD_D00932Fluoxetine0.000030%
The 1th Page    1 2 3 4    Next   Last    Total 4 Pages